Fibrinolytics in the treatment of complicated pneumonia in pediatrics: An integrative review

Authors

DOI:

https://doi.org/10.33448/rsd-v13i9.46860

Keywords:

Pneumonia; Pediatrics; Empyema; Pleural effusion; Fibrinolytics.

Abstract

Introduction: Community-Acquired Pneumonia (CAP) is a significant pulmonary infection, particularly in children under five years old, with high mortality in developing countries. Severe complications, such as pleural effusion and empyema, are common and are associated with clinical deterioration and prolonged hospitalization. Objective: This study aims to conduct an integrative literature review to evaluate the indications and effectiveness of fibrinolytic therapy in cases of complicated pneumonia in pediatrics. Methodology: This study conducted an integrative literature review using the LILACS, SciELO, and MEDLINE databases via PubMed, with descriptors such as "fibrinolytics," "complicated pneumonia," "pleural effusion," and "children," considering articles published between 2020 and 2024. Results: A total of 98 articles were identified, of which 9 met the inclusion criteria and were analyzed. Discussion: Fibrinolytic therapy has the potential to reduce hospital stay and the complications associated with the treatment of pleural effusion and empyema in children. However, the heterogeneity of the data and the discrepancies in study results indicate the need for further clinical research to establish safer and more effective protocols. Conclusion: Despite advances in the treatment of complicated CAP, significant gaps in the literature still limit the full understanding of the efficacy of fibrinolytic therapy. Additional studies are needed to provide more consistent data and clear guidelines on managing these complications in pediatrics.

References

Allin, E., Nama, N., Irvine, M. A., Pawliuk, C., Wright, M., & Carwana, M. (2021). Conservative and surgical modalities in the management of paediatric parapneumonic effusion and empyema: a protocol for a living systematic review and network meta-analysis. BMJ open, 11(3), e045010.

Al-Shamrani, A. S. (2020). Management of Complicated Pneumonia in Children: Evidence Beyond Guidelines. American Journal of Pediatrics, 6(3), 247-259.

Benedictis, F. M., Kerem, E., Chang, A. B., Colin, A. A., Zar, H. J., & Bush, A. (2020). Complicated pneumonia in children. The Lancet, 396(10253), 786-798.

Buonsenso, D., Cusenza, F., Passadore, L., Bonanno, F., Calanca, C., Mariani, F., ... & Esposito, S. (2024). Parapneumonic empyema in children: a scoping review of the literature. Italian Journal of Pediatrics, 50(1), 136.

Bhate, S., Shinde A., NathaMhaske S., & Kothari R., (2020). Management of pediatric empyema with intrapleural streptokinase: randomised control trial. European Journal of Molecular & Clinical Medicine, 7(02), 2020.

Chibuk, T. K., Cohen, E., Robinson, J. L., Mahant, S., Hartfield, D. S., & Canadian Paediatric Society. (2011). Paediatric complicated pneumonia: diagnosis and management of empyema. Paediatrics & Child Health, 16(7), 425-427.

Chong, W. H., Hu, K., Saha, B. K., & Chopra, A. (2021). Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis. Pulmonary Pharmacology & Therapeutics, 71, 102081.

Christensen, T. D., Bendixen, M., Skaarup, S. H., Jensen, J. U., Petersen, R. H., Christensen, M., ... & Laursen, C. B. (2022). Intrapleural fibrinolysis and DNase versus video-assisted thoracic surgery (VATS) for the treatment of pleural empyema (FIVERVATS): protocol for a randomised, controlled trial–surgery as first-line treatment. BMJ open, 12(3), e054236.

Ciftci, T. T., Akinci, D., Unal, E., Tanır, G., Artas, H., & Akhan, O. (2021). Percutaneous management of complicated parapneumonic effusion and empyema after surgical tube thoracostomy failure in children: a retrospective study. Diagnostic and Interventional Radiology, 27(3), 401.

Derderian, S. C., Meier, M., Partrick, D. A., Demasellis, G., Reiter, P. D., Annam, A., & Bruny, J. (2020). Pediatric empyemas–Has the pendulum swung too far?. Journal of Pediatric Surgery, 55(11), 2356-2361.

Diez, J. R. V., Perez, M. L. M., Malayan, G. V., & Cenabre, M. V. L. (2020). Loculated empyema in a neonate successfully treated with chest tube thoracostomy and antibiotics. Respiratory Medicine Case Reports, 31, 101274.

Elviro, C. F., Longcroft-Harris, B., Allin, E., Leache, L., Woo, K., Bone, J. N., ... & Shawqi, M. M. (2023). Conservative and Surgical Modalities in the Management of Pediatric Parapneumonic Effusion and Empyema: A Living Systematic Review and Network Meta-Analysis. Chest, 164(5), 1125-1138.

Haggie, S., Gunasekera, H., Pandit, C., Selvadurai, H., Robinson, P., & Fitzgerald, D. A. (2020). Paediatric empyema: worsening disease severity and challenges identifying patients at increased risk of repeat intervention. Archives of Disease in Childhood, 105(9), 886-890.

Hoshino, T., Nishima, D., Enseki, M., Umehara, N., Fukasawa, C., & Ishiwada, N. (2022). Pediatric parapneumonic effusion/pleural empyema in Japan: a nationwide survey. The Pediatric Infectious Disease Journal, 41(1), 20-23.

James, C. A., Lewis, P. S., Moore, M. B., Wong, K., Rader, E. K., Roberson, P. K., ... & Ashton, D. J. (2022). Efficacy of standardizing fibrinolytic therapy for parapneumonic effusion. Pediatric Radiology, 52(12), 2413-2420.

Li, S. T. T., & Tancredi, D. J. (2010). Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics, 125(1), 26-33.

Messinger, A. I., Kupfer, O., Hurst, A., & Parker, S. (2017). Management of pediatric community-acquired bacterial pneumonia. Pediatrics in Review, 38(9), 394-409.

Popovsky, E. Y., & Florin, T. A. (2022). Community-acquired pneumonia in childhood. Encyclopedia of Respiratory Medicine, 119.

Rodríguez, M. R. I., Pérez, J. I. G., Rueda, F. V., Pascual, F. J. M., Torres, S. R. W., & Esteban, R. M. P. (2022). Fibrinolysis versus thoracoscopy: comparison of results in empyema management in the child. Annals of Thoracic Medicine, 17(3), 145-150.

Souza, M. T. D., Silva, M. D. D., & Carvalho, R. D. (2010). Integrative review: what is it? How to do it?. Einstein 8, 102-106.

Spencer, D. A., & Cliff, D. (2008). The changing epidemiology of parapneumonic empyema in children. Paediatrics and Child Health, 18(11), 513-518.

Published

23/09/2024

How to Cite

MELO, I. C. P. de .; ROCHA, C. C. O. E. .; VIEIRA, T. P. .; DANTAS , M. E. T. . Fibrinolytics in the treatment of complicated pneumonia in pediatrics: An integrative review . Research, Society and Development, [S. l.], v. 13, n. 9, p. e8113946860, 2024. DOI: 10.33448/rsd-v13i9.46860. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/46860. Acesso em: 26 dec. 2024.

Issue

Section

Health Sciences